FibroBiologics, Inc. (FBLG)
Nasdaq: FBLG · Pharmaceutical Preparations · Houston, TX · filing with the SEC since 2023
Who owns FibroBiologics, Inc.
As filed with the SECHolders of 5% or more
4
Pete O'Heeron holds 18.2% of Common Stock, as its SCHEDULE 13G filed Feb 12, 2025 says.
Directors and officers
10
report now, of 12 people on the record since 2024. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 4 named at left.
Holders of 5% or moreshare of the class, as filed
Pete O'Heeron
SCHEDULE 13G · filed Feb 12, 2025 · Common Stock
Armistice Capital, LLC
SCHEDULE 13G · filed Aug 14, 2026 · Common Stock, $0.00001 par value
Hamid Khoja
SCHEDULE 13D · filed Sep 17, 2026 · Common Stock
Mike Newlin
SCHEDULE 13G · filed Jun 6, 2025 · Common Stock, $0.00001 par value
Lind Global Fund III LP
SCHEDULE 13G · filed Apr 9, 2026 · Common Stock, $0.00001 par value · reported falling below 5%
Blackrock, Inc.
SCHEDULE 13G/A · filed Jul 17, 2025 · Common Stock · reported falling below 5%, from 5.1% in Jan 30, 2025
What FBLG reports owning in othersstakes of 5% or more, and other ties
Other ties the annual report names
Gem Global Yield LLC SCS
An entity · legal entity · owns, named in the 10-K filed Feb 24, 2026
1 subsidiary in 1 country, from the list filed with the 10-K filed Feb 24, 2026.
Insider tradesForm 4
0sales
7purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$100,000bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window4 of 12 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| O'Heeron Pete | CHIEF EXECUTIVE OFFICER | 0 | $0 | 0 | 3 | $0 |
| Garcia Ruben A | General Counsel | 0 | $0 | 0 | 2 | $100,000 |
| Davis Jason | Chief Financial Officer | 0 | $0 | 0 | 1 | $0 |
| Khoja Hamid | Chief Scientific Officer | 0 | $0 | 0 | 1 | $0 |